Bluestar Operations, LLC v. U. S. Drug Enforcement Administration
- Scheduled
- Argued (current)
- Opinion Issued
Challenge to DEA action interpreting hemp-derived HHC as a Schedule I controlled substance.
Panel
Citation
Arguing Counsel
Panel That Day
0 of 5 cases argued September 18, 2026 before this panel have been decided.
No opinions from this panel have been decided yet, so authorship can't be narrowed — the 5 pending opinions could come from any of the panelists.
This is a statistical guess based on prior sittings in this dataset, not a prediction of the ruling.
Predicted Opinion Release
Likely between November 6, 2026 and April 11, 2027, with December 14, 2026 the most likely date.
Argued 40 days ago. Comparable cases at this stage almost always still pending — there's no useful tightening yet.
80% predictive interval from a log-logistic accelerated-failure-time model fit on 2,134 prior decided cases plus 111 currently-pending cases as right-censored evidence. Updates as days pass with no opinion. How this is calculated →